Document is current

Article History

Received: 16 May 2024

Accepted: 30 July 2024

First Online: 25 September 2024

Declarations

:

: Alexis Ogdie is a consultant for AbbVie, Amgen, Bristol Myers Squibb, Celgene, CorEvitas, Eli Lilly, Gilead Sciences, GSK, Janssen, Novartis, Pfizer Inc, and UCB, and has received grant/research support from AbbVie, Amgen, Novartis, and Pfizer Inc. Lars E. Kristensen is a consultant for AbbVie, Biogen, Eli Lilly, Galapagos NV, Gilead Sciences, Janssen, Pfizer Inc, Sanofi, and UCB, and has received grant/research support from AbbVie, Eli Lilly, Pfizer Inc, and UCB. Enrique R. Soriano is an advisor for Janssen, a consultant for AbbVie, Eli Lilly, Janssen, Novartis, Pfizer Inc, and UCB, and has received grant/research support from AbbVie, Janssen, Novartis, Pfizer Inc, Roche, and UCB. Servet Akar is an advisor for AbbVie, Amgen, Eli Lilly, Novartis, Pfizer Inc, Sanofi, TRPharm, and UCB. Yanhui Sun was an employee and shareholder of Pfizer Inc at the time of the study, and is currently an employee of Rundo Med-Tech, Shanghai, China. David Gruben and Lara Fallon are employees and shareholders of Pfizer Inc. Cassandra D. Kinch was an employee and shareholder of Pfizer Inc at the time of the study. Dafna D. Gladman is a consultant for AbbVie, Amgen, Bristol Myers Squibb, Celgene, Eli Lilly, Galapagos, Gilead Sciences, Janssen, Novartis, Pfizer Inc, and UCB, and has received grant/research support from AbbVie, Amgen, Celgene, Eli Lilly, Novartis, Pfizer Inc, and UCB.

: All studies were conducted in accordance with the principles of the Declaration of Helsinki and Good Clinical Practice Guidelines of the International Council for Harmonisation and were approved by the relevant Institutional Review Board and/or Independent Ethics Committee at each investigational site [–]. Patients provided written, informed consent.